Dr. Recknor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2350 Limestone Pkwy
Gainesville, GA 30501Phone+1 770-534-5154Fax+1 770-503-0183
Education & Training
- Medical University of South CarolinaResidency, Internal Medicine, 1992 - 1994
- Medical University of South CarolinaResidency, Surgery, 1991 - 1991
- Medical University of South CarolinaClass of 1991
Certifications & Licensure
- GA State Medical License 1995 - 2025
- SC State Medical License 1993 - 1995
Clinical Trials
- A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 50 citationsComparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.Robert R. Recker, David L. Kendler, Christopher Recknor, Theodore W. Rooney, E. Michael Lewiecki
Bone. 2007-04-01 - 58 citationsThe Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.Christopher Recknor, Robert R. Recker, Charles Benson, Deborah A. Robins, Alan Y Chiang
Journal of Bone and Mineral Research. 2015-09-01 - 89 citationsThe effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.Peyman Hadji, J.R. Zanchetta, L.A. Russo, Christopher Recknor, Kenneth G. Saag
Osteoporosis International. 2012-08-01
Press Mentions
- Researchers Had Previously Suspected That an Overactive Immune System Was the Root of the Syndrome – ScienceDailyApril 25th, 2022
- CytoDyn to Hold Webcast and Live Q/A on October 26October 21st, 2021
- CytoDyn to Present at Emerging Growth Conference on October 13 Followed by Live Q/AOctober 7th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: